2. ď˝ Headache arises from activation of pain-sensitive intracranial
structures.
ď˝ 1930s- Ray and Wolfe identified intracranial pain sensitive
strucutres
INTRACRANIAL EXTRACRANIAL
â˘arteries of the circle of Willis
â˘the first few centimeters of their
medium- sized branches,
â˘meningeal (dural) arteries
â˘large veins and dural venous sinuses
â˘portions of dura near blood vessels.
â˘external carotid artery and its
branches
â˘scalp and neck muscles,
â˘skin and cutaneous nerves
â˘cervical nerves and nerve roots
â˘mucosa of sinuses,
â˘teeth.
3.
4. MIGRAINE
â˘Global Burden of Disease
Survey 2010- 3rd most
prevalent disorder
â˘7th specific cause of
disability worldwide
5. Meet criteria, but <5
attacks, - 1.5.1 - Probable
migraine without aura.
When pt. falls asleep
during an attack and
wakes up without it,
duration of attack is
reckoned until waking.
In age < 18 years: 2-72
hours
POUND
6. Aphasia is always regarded as a
unilateral symptom;
dysarthria may or may not be.
Visual aura in > 90%
Positive / negative phenomenon
Visual Aura Rating Scale
Next in freq- sensory disturbances
Positive / negative phenomenon
Less frequent - speech distr. Aphasic
Positive / negative phenomenon
Aura of motor weakness- Hemiplegic
migraine
Symptoms of these aura may follow one
another in successionď visual ď sensory
ď language
7. VARS score :- 5 visual symptom characteristics
ď˝ duration 5-60 min (3 points)
ď˝ develops gradually > or = 5 min (2 points)
ď˝ scotoma (2 points)
ď˝ zig-zag lines (2 points)
ď˝ unilateral (1 point).
⌠Max- 10 points.
⌠Score > or = 5 ď diagnosed as Migraine Aura
⌠Sensitivity - 96% and Specificity - 98%
8.
9.
10.
11.
12.
13.
14. PREVIOUSLY USED TERMS:
â˘Tension headache
⢠muscle contraction headache
â˘Psychomyogenic headache
â˘stress headache
â˘Ordinary headache
â˘essential headache
â˘idiopathic headache
â˘Psychogenic headache
How to elicit pericranial tenderness
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
27.
28.
29.
30. ď˝ no receptor specificity.
ď˝ have effects at
⌠5-HT1B and 5-HT1D receptors,
⌠5-HT1F, 5-HT1A, 5-HT2A, 5-HT2B,
⌠Dopamine D1 and D2, & adrenergic a1, a2, and b receptors
⌠half-life - 36 h, helpful in long duration migraine
31.
32. ď˝ Corticosteroids
⌠Intractable Migraine or Status Migrainosus.
⌠a rapidly tapering dose of Prednisone beginning with 60 mg
⌠or a 3-day pulse thr. of Dexamethasone (4 mg tid, bid, qd)
ď˝ Antiemetics
⌠Neuroleptics antagonize dopamine receptors in CTZ
⌠Commonly used
ď metoclopramide, chlorpromazine, prochlorperazine, promethazine, haloperidol
ď˝ Narcotic analgesics
⌠when other medications cannot be used
⌠reserved for pts with CAD
⌠pregnant women.
33.
34.
35.
36.
37.
38.
39. ď˝ Steroid- Pred, M-pred, Triamcinolone
ď˝ Ergot tartarate/ DHE
ď˝ CCB- Verapamil
ď˝ Lithium- adv efects- DI and thirst, GI distr, Tremors
Treatment in difficult cases:
ď˝ combination of
⌠verapamil and topiramate
⌠or verapamil and lithium
ď˝ For particularly resistant headaches, triple therapy
⌠verapamil with either topiramate or valproate plus lithium.
40. ď˝ adverse events
⌠corneal anesthesia,
⌠keratitis,
⌠anesthesia dolorosa.
ď˝ benefit may be short lasting, used only rarely
47. ď˝ Daroff RB, Jankovic J, Mazziotta JC, Pomeroy SL. Bradley's neurology in
clinical practice. Elsevier Health Sciences; 2015 Oct 25
ď˝ Headache Classification Committee of the International Headache Society
(IHS. The international classification of headache disorders, (beta version).
Cephalalgia. 2013 Jul 1;33(9):629-808.
ď˝ Tepper SJ, Tepper DE, editors. The Cleveland Clinic manual of headache
therapy. Springer; 2011 Aug 22.